LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
BCIQ Data Coverage
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
3rd Biotech CEO & Investor Reception
East-West Biopharma Summit 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Clear Labs Inc.
Headquarters:
San Carlos, CA, United States
Website:
https://www.clearlabs.com/
Year Founded:
2014
Status:
Private
BioCentury
|
Jul 14, 2022
Management Tracks
Cantrell joins Brii as CBO
Plus Chan Lee to be general counsel at BeiGene and updates from CytoDyn, Kezar, Anaveon, Fulcrum and more
Read More
BioCentury
|
Jan 8, 2022
Management Tracks
Totus recruits Singer as first CFO
Plus updates from Pharmaron, Adverum, Azenta, InterVenn and more
Read More
BioCentury
|
May 27, 2021
Deals
May 26 Quick Takes: Akili raises $160M to take digital therapeutic to market; plus venture rounds for Engine and Clear, Lyell’s IPO and a $1.4B takeout for Vectura
With $110 million in a series D equity round plus a $50 million credit facility, Akili Interactive Labs Inc. will accelerate its go-to-market strategy for digital therapeutic EndeavorRx to treat ADHD.
Read More
Items per page:
10
1 - 3 of 3